Skip to main content
logo
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.570
-0.160 (-9.25%)
At close: Jun 4, 2026, 4:00 PM EDT
1.627
+0.056 (3.60%)
After-hours: Jun 4, 2026, 6:56 PM EDT

China SXT Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
1.541.741.931.972.64.78
Revenue Growth (YoY)
-15.42%-9.73%-2.19%-24.23%-45.53%-7.45%
Cost of Revenue
1.21.371.371.551.351.94
Gross Profit
0.330.370.550.431.252.84
Selling, General & Admin
8.723.053.076.036.445.04
Total Operating Expenses
8.723.053.076.036.445.04
Operating Income
-8.38-2.68-2.52-5.61-5.19-2.2
Total Non-Operating Income (Expense)
-0.49-0.62-0.58-0.33-0.22-0.74
Pretax Income
-8.87-3.3-3.1-5.93-5.41-2.94
Provision for Income Taxes
-----0.330.19
Net Income
-8.87-3.3-3.1-5.93-5.74-2.75
Net Income to Common
-8.87-3.3-3.1-5.93-5.74-2.75
Shares Outstanding (Basic)
11610000
Shares Outstanding (Diluted)
11610000
Shares Change (YoY)
3490.69%1212.67%224.91%541.91%44.50%132.78%
EPS (Basic)
-2.13-2.32-28.58-177.84-1103.34-763.80
EPS (Diluted)
-2.13-2.32-28.58-177.84-1103.34-763.80
Shares Outstanding
116.0313.760.280.060.010
Free Cash Flow
-2.78-2.35-1.94-0.150.21-1.41
Free Cash Flow Per Share
-0.02-1.65-17.85-4.5439.59-391.80
Gross Margin
21.74%21.11%28.73%21.62%48.10%59.44%
Operating Margin
-544.94%-153.97%-130.42%-284.40%-199.43%-45.99%
Profit Margin
-576.72%-189.77%-160.67%-301.00%-195.21%-65.59%
FCF Margin
-180.97%-134.83%-100.34%-7.68%7.91%-29.50%
EBITDA
-8.34-2.6-2.31-5.36-4.87-1.85
EBITDA Margin
-541.96%-149.24%-119.88%-271.72%-187.13%-38.76%
EBIT
-8.38-2.68-2.52-5.61-5.19-2.2
EBIT Margin
-544.94%-153.97%-130.42%-284.40%-199.43%-45.99%
Effective Tax Rate
-0.00%0.00%0.00%6.07%-6.55%
SEC Filings: 10-K · 10-Q